Get startedLog in
    Picture of Sutro Biopharma logo

    STRO — Sutro Biopharma News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapSucker Stock
    All News

    Brief: Sutro Biopharma And Vaxcyte Enter Into Option Grant Agreement For The Development And Manufacturing Rights Of Cell-Free Extract

    Picture of Sutro Biopharma logoSutro Biopharma
    20/12/2022 21:08
    Dec 20 (Reuters) - Vaxcyte Inc  PCVX.O :
    * SUTRO BIOPHARMA AND VAXCYTE ENTER INTO OPTION GRANT
AGREEMENT
FOR THE DEVELOPMENT AND MANUFACTURING RIGHTS OF CELL-FREE
EXTRACT
    * SUTRO BIOPHARMA- TO RECEIVE $22.5 MILLION IN UPFRONT
PAYMENTS &
IS ELIGIBLE FOR UP TO ADDITIONAL $135 MILLION PENDING OPTION
EXERCISE & FROM OTHER MILESTONES
    * SUTRO BIOPHARMA- NEW AGREEMENT PROVIDES VAXCYTE ACCESS TO
EXPANDED RIGHTS TO DEVELOP, MANUFACTURE CELL-FREE EXTRACT

Source text for Eikon:  ID:nGNX8pw9MZ 
Further company coverage:  PCVX.O 
 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Sutro Biopharma

    See all news